gefitinib has been researched along with gold in 2 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (gold) | Trials (gold) | Recent Studies (post-2010) (gold) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 47,670 | 302 | 31,345 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bierbach, U; Day, CS; Gueble, MJ; Kucera, GL; Pickard, AJ; Qiao, X; Yang, M | 1 |
| Ahmed, M; Carrascosa, LG; Mainwaring, P; Trau, M; Wuethrich, A | 1 |
2 other study(ies) available for gefitinib and gold
| Article | Year |
|---|---|
Synthesis, reactivity, and biological activity of gold(I) complexes modified with thiourea-functionalized tyrosine kinase inhibitors.
Topics: Afatinib; Cell Line; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Dose-Response Relationship, Drug; Gefitinib; Gold; Humans; Inhibitory Concentration 50; Protein Kinase Inhibitors; Quinazolines; Thiourea | 2015 |
An exosomal- and interfacial-biosensing based strategy for remote monitoring of aberrantly phosphorylated proteins in lung cancer cells.
Topics: Adsorption; Cell Line, Tumor; ErbB Receptors; Exosomes; Extracellular Signal-Regulated MAP Kinases; Gefitinib; Gold; Humans; Lung Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Quinazolines | 2018 |